Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The multifunctional low density lipoprotein (LDL) receptor-related protein (LRP) has been postulated to participate in a number of diverse physiological and pathological processes ranging from the homeostasis of plasma lipoproteins, atherosclerosis, and fibrinolysis to neuronal regeneration and survival. It has not been possible to demonstrate in vivo the physiological significance of LRP for each of these complex processes by a conventional gene knockout approach because LRP is essential for embryonic development. Here we have used the Cre/loxP recombination system to achieve inducible, tissue-specific and quantitative disruption of the LRP gene in adult mice. Inactivation of LRP in the livers of LDL receptor-deficient mice resulted in the accumulation of cholesterol-rich remnant lipoproteins in the circulation. In normal animals, this caused a compensatory upregulation of the LDL receptor in the liver. Conditional gene targeting has thus allowed us to isolate a specific physiological function of LRP for in vivo analysis and has provided unequivocal evidence for another LDL receptor-independent cholesterol clearance pathway in liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,983
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Self-citationHerz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H., & Stanley, K. K. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03306.x · Cited by 959
Self-citation
Cited by
Items 301–400 of 453
Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo
Barrett, B. S., Guo, K., Harper, M. S., Li, S. X., Heilman, K. J., Davidson, N. O., & Santiago, M. L. (2014) · Virology · doi:10.1016/j.virol.2014.09.006 · Cited by 20
“ApoB48 is a truncated form of apoB100 that is found primarily in chylomicrons in the small intestine where it can be cleared through LDLR-independent mechanisms (Ishibashi et al., 1994; Rohlmann et al., 1998).”
BackgroundThe Role of Soluble Low-Density Lipoprotein Receptor-Related Protein-1 in Obstructive Sleep Apnoea
Mészáros, M., Kunos, L., Tárnoki, Á. D., Tárnoki, D. L., Lázár, Z., & Bikov, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071494 · Cited by 22
“Inactivation of hepatic LRP-1 gene in mice resulted in decreased cholesterol-rich remnant lipoproteins clearance with consequential accumulation of these lipoproteins in the circulation [12], implicating that dyslipidaemia could be not only the reason for but the consequence of low LRP-1 levels.”
de Man, F. H. A. F., de Beer, F., van der Laarse, A., Jansen, H., Leuven, J. A. G., Souverijn, J. H. M., Vroom, T. F. F. P., Schoormans, S. C. M., Fruchart, J., Havekes, L. M., et al. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00409-3 · Cited by 21
“Since LRP mainly binds chylomicron remnants, its contribution to the clearance of VLDL is considered to be limited [37,38].”
BackgroundKim, S. S., Kim, C. H., & Vaziri, N. D. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2004 · Cited by 20
“Subsequent studies demonstrated the role of LRP as a receptor for chylomicron and VLDL remnants (apoE and apoB48 serving as the ligands) (1, 11, 12, 22, 44), hepatic lipase (9, 10), and lipoprotein lipase (2, 20, 46).”
BackgroundKawashiri, M., Zhang, Y., Usher, D. C., Reilly, M. P., Puré, E., & Rader, D. J. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31618-7 · Cited by 22
Herijgers, N., Eck, M. V., Korporaal, S. J. A., Hoogerbrugge, P. M., & van Berkel, T. J. C. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32023-x · Cited by 20
A novel ARH splice site mutation in a Mexican kindred with autosomal recessive hypercholesterolemia
Canizales‐Quinteros, S., Aguilar-Salinas, C. A., Huertas‐Vázquez, A., Ordóñez-Sánchez, M. L., Rodríguez-Torres, M., Ventura-Gallegos, J. L., Riba, L., Ramírez-Jiménez, S., Salas-Montiel, R., Medina-Palacios, G., et al. (2004) · Human Genetics · doi:10.1007/s00439-004-1192-9 · Cited by 21
“LRP is abundantly expressed in liver where it acts in concert with the LDLR in the clearance of chylomicron remnants (Rohlmann et al. 1998).”
BackgroundGenetic manipulation of brain endothelial cells in vivo
Assmann, J. C., Körbelin, J., & Schwaninger, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.006 · Cited by 23
Teusink, B., Mensenkamp, A. R., van der Boom, H., Kuipers, F., van Dijk, K. W., & Havekes, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106396200 · Cited by 20
A Gene-targeted Mouse Model for Familial Hypobetalipoproteinemia
Kim, E. J., Ambroziak, P., Véniant, M. M., Hamilton, R. L., & Young, S. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33977 · Cited by 20
Differential cholesterol uptake in liver cells: A role for PCSK9
Luquero, A., Vilahur, G., Casaní, L., Badimón, L., & Borrell-Pagés, M. (2022) · The FASEB Journal · doi:10.1096/fj.202101660rr · Cited by 19
Plasmodium Sporozoite Passage across the Sinusoidal Cell Layer
Frevert, U., Усынин, И. Ф., Baer, K., & Klotz, C. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-0-387-78267-6_15 · Cited by 24
Oldoni, F., van Capelleveen, J. C., Dalila, N., Wolters, J. C., Heeren, J., Sinke, R. J., Hui, D. Y., Dallinga‐Thie, G. M., Frikke‐Schmidt, R., Hovingh, K., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310309 · Cited by 19
Takanashi, M., Kimura, T., Li, C., Tanaka, M., Matsuhashi, A., Yoshida, H., Noda, A., Xu, P., Takase, S., Okazaki, S., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311931 · Cited by 19
Soluble Low-Density Lipoprotein Receptor–Related Protein
Grimsley, P. G., Quinn, K., & Owensby, D. A. (1998) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(98)00029-2 · Cited by 22
“(1995) and references therein, Rohlmann et al. (1998)”
López‐Soldado, I., Avella, M., & Botham, K. M. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.012 · Cited by 21
Moon, J. H., Kim, H. J., Kim, H. M., Yang, A. H., Lee, B., Kang, E. S., Lee, H. C., & Soo, B. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0119 · Cited by 22
“In addition, previous studies reported that hepatic LRP1 deficiency did not influence serum triglyceride level (Rohlmann et al. 1998, Basford et al. 2011).”
BackgroundInfluentialSpermatocyte-Specific Gene Excision by Targeted Expression of Cre Recombinase
Ando, H., Haruna, Y., Miyazaki, J., Okabe, M., & Nakanishi, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2762 · Cited by 18
Osuga, J.-I., Yonemoto, M., Yamada, N., Shimano, H., Yagyu, H., Ohashi, K., Harada, K., Kamei, T., Yazaki, Y., & Ishibashi, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1124 · Cited by 18
“Apo B‐associated radioactivity was determined using the isopropanol precipitation method as previously described ( 9 ).”
MethodShang, N., Bhullar, K. S., & Wu, J. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c04064 · Cited by 17
LDL receptor-related protein 1 and its interacting partners in tissue homeostasis
Jaeschke, A., & Hui, D. Y. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000776 · Cited by 21
“However, the LDL receptor can serve similar functions hence the inactivation of both LDL receptor and LRP1 in the liver is necessary to cause cholesteryl ester-rich remnant lipoprotein accumulation in circulation [3].”
BackgroundRaikwar, N. S., Cho, W. K., Bowen, R. F., & Deeg, M. A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00593.2004 · Cited by 17
“Consistent with this possibility is our observation that the magnitude of the increase in fasting triglycerides and postprandial triglycerides and the twofold decrease in catabolism of triglyceride-rich lipoproteins by overexpressing hepatic GPI-PLD are comparable to the changes seen in mice lacking the LDLR (20) or h…”
BackgroundInteractions of Lipoproteins with Proteoglycans
Williams, K. J. (2003) · Proteoglycan Protocols · doi:10.1385/1-59259-209-0:457 · Cited by 17
Sposito, A. C., Santos, R. D., Hueb, W. A., Ventura, L. I., Vinagre, C. G. C., Ramires, J. A. F., & Maranhão, R. C. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00661-x · Cited by 18
“Studies performed in animal models suggest that after entering the space of Disse chylomicron remnants are effectively removed from the plasma by the LDL receptor and the LRP [9,10].”
BackgroundFoiani, M., Ferrari, M., Liberi, G., Lopes, M., Lucca, C., Marini, F., Pellicioli, A., Muzi-Falconi, M., & Plevani, P. (1998) · Biological Chemistry · doi:10.1515/bchm.1998.379.8-9.1019 · Cited by 18
ROLE OF THE ENTEROHEPATIC CIRCULATION OF BILE SALTS IN LIPOPROTEIN METABOLISM
Cooper, A. D. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70051-0 · Cited by 18
Strickland, D. K., & Medved, L. V. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01987.x · Cited by 17
Yu, K. C.-W., Jiang, Y., Chen, W., & Cooper, A. D. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34907-5 · Cited by 21
Vos, D. Y., Wijers, M., Smit, M., Huijkman, N., Kloosterhuis, N. J., Wolters, J. C., Tissink, J. J., Pronk, A. C. M., Kooijman, S., Rensen, P. C. N., et al. (2023) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.122.318169 · Cited by 16
Perona, J. S., Avella, M., Botham, K. M., & Ruíz-Gutiérrez, V. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061730 · Cited by 16
“1992), and then their remnants may be taken up by the liver (Cooper, 1997; Rohlmann et al. 1998; Zeng et al. 1998).”
BackgroundInfluentialThe low-density lipoprotein receptor family: Genetics, function, and evolution
Schneider, W. J., Nimpf, J., Brandes, C., & Drexler, M. (1999) · Current Atherosclerosis Reports · doi:10.1007/s11883-999-0007-9 · Cited by 18
“On the other hand, 1) LRP physiologically substitutes for the LDLR in hepatic clearance of chylomicron remnants (which also bind to the LDLR) [ 56 ]; 2) VLDLR, not expressed in the liver and normally not significantly involved in lipoprotein metabolism, can, when expressed in the liver, substitute for the LDLR [57, 58…”
BackgroundZhang, J. M., Au, D. T., Sawada, H., Franklin, M., Moorleghen, J. J., Howatt, D. A., Wang, P., Aicher, B. O., Hampton, B., Migliorini, M. M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.164751 · Cited by 15
“LRP1 is a large endocytic signaling receptor that contributes to vascular development (9), exerts a role in lipoprotein metabolism (10, 11), regulates protease concentrations (5, 12, 13), regulates inflammation (14), and attenuates the progression of atherosclerosis and aneurysm formation (4–8).”
BackgroundKidney and lipids: novel potential therapeutic targets for dyslipidemia in kidney disease?
Zuzda, K., Grycuk, W., Małyszko, J. S., & Małyszko, J. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2161887 · Cited by 17
“non-esterified free fatty acids (Table 1) [1-8].”
BackgroundTwo weeks of high‐fat feeding disturb lipid and cholesterol molecular markers
Tomaz, L. M., Melbouci, L., Mercier, J., Ou, Y., Auclair, N., Lira, F. S., Lavoie, J.-M., & St‐Pierre, D. H. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3358 · Cited by 20
“R, plasma remnant LDL particles are taken up by low‐density lipoprotein receptor‐related protein 1 (LRP‐1), a protein that has structural and biochemical similarities to LDL‐R.18 LRP‐1 gene expression was also increased by the present 2 weeks HFD, supporting the interpretation that indeed hepatic cholesterol transport…”
BackgroundInfluentialYu, K. C.-W., Jiang, Y., Chen, W., & Cooper, A. D. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31965-9 · Cited by 21
Two weeks of western diet disrupts liver molecular markers of cholesterol metabolism in rats
St-Amand, R., Sock, E. T. N., Quinn, S., Lavoie, J.-M., & St-Pierre, D. H. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01351-2 · Cited by 21
Covarrubias, R., Wilhelm, A. J., & Major, A. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102236 · Cited by 15
“Briefly, mice harboring loxP sites flanking the LRP gene [38] were crossed with mice expressing cre-recombinase under the control of macrophage LyzM promoter [39].”
BackgroundMethodPetersen, H. H., Hilpert, J., Jacobsen, C. B., Lauwers, A., Roebroek, A., & Willnow, T. E. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.069 · Cited by 14
Perona, J. S., Avella, M., Botham, K. M., & Ruíz-Gutiérrez, V. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507793868 · Cited by 14
Treatment of dyslipidaemia in HIV-infected persons
Manuel, O., Thiébaut, R., Darioli, R., & TARR, P. E. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.10.1619 · Cited by 13
Fitusiran reduces bleeding in factor X–deficient mice
Verhenne, S., McCluskey, G., Maynadié, H., Adam, F., Casari, C., Panicot‐Dubois, L., Crescence, L., Dubois, C., Denis, C. V., Lenting, P. J., et al. (2024) · Blood · doi:10.1182/blood.2023023404 · Cited by 12
Liu, R., Wang, L., Sun, Y., Wang, L., Zhang, H., & Song, L. (2013) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2013.11.017 · Cited by 13
Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response
Dato, V. A., Amaro, A. B., García, E., Claudi, L., Lhoëst, M. T. L. C., Iborra, A., Escolá‐Gil, J. C., Palmero, M. J. G., Samouillan, V., Enrich, C., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113270 · Cited by 12
Eck, M. V., Dijk, K. W. V., Herijgers, N., Hofker, M. H., Groot, P. H., & Berkel, T. J. V. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00471-8 · Cited by 14
“Furthermore, liver-specific inactivation of LRP in LDL receptor-deficient mice by conditional gene targeting induced accumulation of mainly LDL cholesterol and to a lesser extent VLDL cholesterol, whereas in wild-type animals this caused a compensatory up regulation of the LDL receptor in the liver [18].”
BackgroundSock, E. T. N., Mayer, G., & Lavoie, J.-M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159550 · Cited by 13
“LRP-1 binds to apolipoprotein E and serves as a receptor for remnant lipoproteins in the liver, thus playing an important role in clearing these atherogenic particles [51, 52].”
BackgroundShrestha, P., Yazdani, S., Vivès, R. R., Masri, R. E., Dam, W., van de Sluis, B., & van den Born, J. (2021) · Kidney International · doi:10.1016/j.kint.2021.01.023 · Cited by 14
“Heparin and related compounds are known to lower plasma TG concentrations by releasing lipoprotein lipase into plasma.(74,75) However, not only TGs but also TC reduce under heparin treatment, which cannot be explained by a lipoprotein lipase–releasing”
BackgroundDistribution of apolipoprotein E among lipoprotein fractions in the lactating cow
Takahashi, Y. K., Itoh, F., Oohashi, T., & Miyamoto, T. (2003) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpc.2003.09.004 · Cited by 12
Fazavana, J., Muczynski, V., Proulle, V., Wohner, N., Christophe, O. D., Lenting, P. J., & Denis, C. V. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13502 · Cited by 11
Akbar, S., Pinçon, A., Lanhers, M., Claudepierre, T., Corbier, C., Gregory, L., Malaplate, C., Visvikis, A., Oster, T., & Yen, F. T. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00077.2016 · Cited by 12
“In view of LSR’s role in the hepatic clearance of TGRL during the postprandial phase (30, 40) and the liver being the major site of influx and efflux of lipids, the goal of this study was to study changes in expression of genes involved in hepatic lipid metabolism as a result of LSR heterozygosity (LSR / ) and compare…”
BackgroundInfluentialEDEM3 Modulates Plasma Triglyceride Level Through Its Regulation of LRP1 Expression
Xu, Y., Peloso, G. M., Nagai, T. H., Mizoguchi, T., Deik, A., Bullock, K. H., Lin, H., Musunuru, K., Yang, Q., Vasan, R. S., et al. (2019) · iScience · doi:10.1016/j.isci.2020.100973 · Cited by 11
“Though the mechanisms for LRP1 and LDLR in regulating TG metabolism remain to be determined (Rohlmann et al., 1998), the existing data suggest that LRP1 plays a major role in the clearance of TGLs.”
BackgroundLi, P., Wu, J., Li, Z., & Feng, X.-W. (2015) · Sleep And Breathing · doi:10.1007/s11325-015-1200-4 · Cited by 12
Germ cell specific promoter drives ectopic transgene expression during embryogenesis
Bhullar, B., Schmidt, J. V., Truong, T., Rancourt, D. E., & van der Hoorn, F. A. (2001) · Molecular Reproduction and Development · doi:10.1002/mrd.1003 · Cited by 11
“Speci®c excision events in adult mice were noted using the latter strategies ((Akagi et al., 1997; Rohlmann et al., 1998; Sato et al., 1998; Stec et al., 1999).”
MethodBoucher, P., Ducluzeau, P., Davelu, P., Andréelli, F., Vallier, P., Riou, J. P., Laville, M., & Vidal, H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00169-2 · Cited by 11
van Dijk, K. W., van Vlijmen, B. J. M., de Winther, M. P. J., Hof, B. V. ’., van der Zee, A., van der Boom, H., Havekes, L. M., & Hofker, M. H. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.12.2945 · Cited by 14
Big eater macrophages dominate inflammation resolution following myocardial infarction
Kain, V., & Halade, G. V. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.08.019 · Cited by 13
“Several receptors have been described for macrophages, including CD36, low-density lipoprotein receptorrelated protein 1 (LRP), and MERTK [11,12,13].”
BackgroundAhmad, N., Girardet, J., Akbar, S., Lanhers, M., Paris, C., Yen, F. T., & Corbier, C. (2012) · FEBS Journal · doi:10.1111/febs.12026 · Cited by 10
Liver Physiology and Energy Metabolism
Roy‐Chowdhury, N., & Roy‐Chowdhury, J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00072-x · Cited by 14
Jaeschke, A., Haller, A. M., Cash, J. G., Nam, C., Igel, E., Roebroek, A., & Hui, D. Y. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120001141 · Cited by 11
“hepatocytes have documented its importance for uptake of chylomicron and VLDL remnants (9), HDL secretion, and apoA-I lipidation (10).”
BackgroundFiévet, C., Fruchart, J.-C., & Staels, B. (2007) · Frontiers in bioscience · doi:10.2741/2376 · Cited by 13
Mazura, A. D., & Pietrzik, C. U. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041268 · Cited by 9
“In contrast to the modest quantity of potential ligands and functions of the LDL receptor, LRP1 is a multifunctional receptor participating in numerous physiological processes besides lipoprotein metabolism [66,67], including blood coagulation [68–70], clearance of various proteases and protease inhibitors [71,72], an…”
BackgroundLarios, J. A., & Marzolo, M.-P. (2012) · Frontiers in Biology · doi:10.1007/s11515-011-1186-7 · Cited by 9
“This glycoprotein , which is synthesized as a polypeptide chain of more than 600 kDa, was initially discovered as the receptor that endocytoses the plasma protease inhibitor α2-macroglobulin (α2M) (Moestrup and Gliemann, 1989; Kristensen et al., 1990; Strickland et al., 1990), tissue type plasminogen (tPA) (Bu et al.,…”
BackgroundInfluentialZhu, M., Shen, H., Wang, B., He, Y., Chen, J., Ren, J., Zhang, Z., & Xu, J. (2023) · Oncology Letters · doi:10.3892/ol.2023.14019 · Cited by 13
“Rohlmann et al (35) showed that LDLR partially compensates for the loss of LRP1 in hepatocytes and increased expression of LDLR indicates that LRP1 plays an important role in elimination of residual lipoproteins in the liver.”
Graham, V., Maggio, P. D., Armengol, S., Lawson, C., Wheeler-Jones, C. P. D., & Botham, K. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.11.008 · Cited by 12
Characterization of the adaptor protein ARH expression in the brain and ARH molecular interactions
Mameza, M. G., Lockard, J. M., Zamora, E. D., Hillefors, M., Lavina, Z. S., & Kaplan, B. B. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04854.x · Cited by 13
“Low density lipoprotein receptor-related protein 1 is highly expressed in neurons and mediates endocytosis of a broad range of ligands in hepatocytes such as chylomicron remnants and protease–protease inhibitor complexes (Herz and Strickland 2001; Rohlmann et al. 1998).”
BackgroundFarahnak, Z., Côté, I., Sock, E. T. N., & Lavoie, J.-M. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0128-9 · Cited by 9
Proteases and Lipoprotein Receptors in Alzheimer's Disease
Makarova, A., Williams, S. E., & Strickland, D. K. (2004) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:41:1:139 · Cited by 13
Wholegrain oat diet changes the expression of genes associated with intestinal bile acid transport
Andersson, K. E., Chawade, A., Thuresson, N., Rascón, A., Öste, R., Sterner, O., Olsson, O., & Hellstrand, P. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600874 · Cited by 9
Azhar, S., Medicherla, S., Shen, W., Fujioka, Y., Fong, L. G., REAVEN, E. P., & Cooper, A. D. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600349-jlr200 · Cited by 12
“lished ( 54 ), the precise mechanism by which this occurs has not been elucidated.”
BackgroundPaying the Iron Price: Liver Iron Homeostasis and Metabolic Disease
Ameka, M., & Hasty, A. H. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210039 · Cited by 18
Dynamic and stable pools of apoE differ functionally at the HepG2 cell surface
Burgess, J. W., & Marcel, Y. L. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30273-x · Cited by 8
Plasmodium sporozoites invade cells with targeted deletions in the LDL receptor related protein
Marshall, P., Rohlmann, A., Nussenzweig, V., Herz, J., & Sinnis, P. (2000) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(99)00210-8 · Cited by 8
“We have previously shown that recombination of the floxed LRP alleles (and consequent inactivation of the LRP gene) could be achieved in essentially 100% of hepatocytes, after induction of the Cre transgene by pI:pC injection [10].”
MethodSelf-citationSomatic gene therapy for dyslipidemias
Belalcazar, M., & Chan, L. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90199-3 · Cited by 8
Guo, P., Yang, L., Zhang, M., Zhang, Y., Tong, Y., Cao, Y., & Liu, J. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001411 · Cited by 7
Structure and Function of the Lipolysis Stimulated Lipoprotein Receptor
Stenger, C., Corbier, C., & Frances, T. (2012) · InTech eBooks · doi:10.5772/34657 · Cited by 14
“increase in apoB48-containing lipoproteins was observed when both hepatic LRP1 and LDL-R were inactive, suggesting that LRP plays a back-up role in the uptake of lipoproteins in the absence of the LDL-R (Rohlmann et al., 1998).”
BackgroundMoreno, J. A., López‐Miranda, J., & Pérez‐Jiménez, F. (2006) · Medicina Clínica · doi:10.1157/13092316 · Cited by 11
Mouse models as tools for dissecting disorders of lipoprotein metabolism
Marschang, P., & Herz, J. (2003) · Seminars in Cell and Developmental Biology · doi:10.1016/s1084-9521(02)00169-6 · Cited by 8
Self-citationLambert, M. S., Avell, M. A., Berhane, Y., Shervill, E., & Botham, K. M. (2001) · British Journal Of Nutrition · doi:10.1079/bjn2000328 · Cited by 7
“…binding to the surface of hepatocytes by acting as a ligand (Diard et al. 1994; Amar et al. 1998; Chappell & Medh, 1998), and they are subsequently endocytosed by receptor-mediated pathways involving either the LDL receptor or the LDL receptor-related protein (Cooper, 1997; Rohlmann et al. 1998).”
BackgroundConditional Animal Models for the Study of Lipid Metabolism and Lipid Disorders
Bock, H. H., Herz, J., & May, P. (2007) · Springer eBooks · doi:10.1007/978-3-540-35109-2_17 · Cited by 6
Self-citationLiu, Z., Andraska, E., Akinbode, D., Mars, W. M., & Mota, R. I. (2022) · Current Pathobiology Reports · doi:10.1007/s40139-022-00231-x · Cited by 4
Parise, F., Simone, L., Croce, M. A., Ghisellini, M., Battini, R., Borghi, S., Tiozzo, R., Ferrari, S., Calandra, S., & Ferrari, S. (1999) · Human Gene Therapy · doi:10.1089/10430349950018201 · Cited by 4
Peptide-mediated targeting of hepatocytes via low density lipoprotein receptor-related protein (LRP)
Ludtke, J. J., Sokoloff, A. V., Wong, S. C., Zhang, G., Strickland, D. K., & Wolff, J. A. (2009) · Drug Delivery · doi:10.1080/10717540902975000 · Cited by 5
“Twenty days later, when the liver LRP expression level was expected to decrease by ∼ 100% (Rohlmann et al., 1998), 1011 pfu of phage was injected.”
BackgroundMethodInfluentialLiver gene disruptions: winners by KO?
Smith, A. J., Ronald, P. J., & Elferink, R. P. J. O. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80359-6 · Cited by 5
Regulation and Clearance of Apolipoprotein B–Containing Lipoproteins
Fazio, S., & Linton, M. F. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50006-8 · Cited by 5
Receptor-Mediated Endocytosis and Intracellular Trafficking of Lipoproteins
Heeren, J., & Beisiegel†, U. (2009) · Springer eBooks · doi:10.1007/978-3-642-00300-4_8 · Cited by 5
Consumption of salmon fishmeal increases hepatic cholesterol content in obese C57BL/6 J mice
Hjorth, M., Doncheva, A. I., Norheim, F., Ulven, S. M., Holven, K. B., Sæther, T., & Dalen, K. T. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02930-y · Cited by 6
“Cholesterol uptake is mediated by three different receptors [35, 36]; LDL receptor (Ldlr; uptake of LDL and chylomicron remnants), the LDL receptor-related protein (Lrp1; uptake of chylomicron remnants) and Scavenger receptor class B type 1 (Scarb1, uptake of HDL).”
BackgroundXiang, Q., Tian, F., Xu, J. R., Du, X., Zhang, S., Guo, L., Zhu, L., Xie, Y., Zang, X., Gui, Y., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159236 · Cited by 4
Evaluation of a method of preparation of lipid emulsions as a model for chylomicron-like particles
Antelo, A., & Perona, J. S. (2013) · Journal of Liposome Research · doi:10.3109/08982104.2012.754464 · Cited by 4
“Chylomicron remnants contain apolipoprotein (apo) B48 as structural protein, secreted as an integral part of the parent chylomicrons, and apo E, which is acquired in the circulation and has a key role in their hepatic uptake (Rohlmann et al., 1998; Yu & Cooper, 2001).”
BackgroundLee, S., Kadambi, S., Yu, K. C.-W., David, C., Azhar, S., Cooper, A. D., & Choi, S. Y. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400184-jlr200 · Cited by 4
“(34) previously reported that inactivation of the LRP gene in mice that expressed functional LDL receptors did not result in the”
BackgroundNiu, A.-D., Lv, Y.-Q., Chen, Y., Liu, Y., Luo, C.-J., Zheng, M., Shen, Y., He, J., Yao, D., Lan, H., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102319 · Cited by 5
“Instead, these receptors recognize specific apolipoproteins, most notably ApoE, which is present on the surface of lipoprotein particles such as LDL and VLDL [37].”
Versatile Functions of Hepatic Lipase in Lipoprotein Metabolism
Dijk, W., Rimbert, A., Sotin, T., May, C. L., & Cariou, B. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323051 · Cited by 4
Huu, T. N., Thanh, H. D., Kim, M.-K., Sah, D. K., Trinh, V. H., Yoon, H. J., Choi, J. M., Lee, G.-H., Kim, S., & Lee, S.-R. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00094-x · Cited by 3
“Treatment with 1,1-DEE restored the key genes involved in the clearance of LDL ( lrp1 87 , and abca1 (log 2 FC = 0.57, p -value 0.05, data not shown) 88,89 ), increase in fatty acid oxidation and decrease in TG synthesis ( ppar δ (log 2 FC = 0.69, p-value 0.05, data not shown) 90,91 , and lepr…”
InfluentialGut Hormones and Inflammatory Bowel Disease
Weng, J., & Lo, C. C. (2025) · Biomolecules · doi:10.3390/biom15071013 · Cited by 7
“Low-density lipoprotein receptor-related protein 1 (LRP1) is a 600 kDa multi-ligand transmembrane receptor [356,357] that facilitates FA uptake in adipose tissue [358–360] and promotes the catabolism of VLDL and chylomicron remnants in hepatocytes via apolipoprotein E binding [361–365].”
Hanse, M., Akbar, S., Layeghkhavidaki, H., & Yen, F. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216298 · Cited by 5
“For the LDL-R-related protein (LRP1), which is an LDL-R family member, accumulation of cholesterol but not TG is observed in hepatic LRP1 KO mice lacking the LDL-R [19].”
BackgroundBejta, F., Napolitano, M., Botham, K. M., & Bravo, E. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.051 · Cited by 3
Metabolism of Chylomicron Cholesterol is Delayed by Estrogen. An In Vivo Study in the Rat
Bravo, E., Cantàfora, A., Avella, M., & Botham, K. M. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122600208 · Cited by 2
Botham, K. M., & Bravo, E. (2019) · CRC Press eBooks · doi:10.1201/9780429063602-8 · Cited by 2
Correction: LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages
Lillis, A. P., Muratoglu, S. C., Au, D. T., Migliorini, M. M., Lee, M., Fried, S. K., MIKHAILENKO, I. A., & Strickland, D. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147457 · Cited by 3
“[4] used a genetic approach to reveal LRP1's role as a chylomicron receptor.”
The CCC Complex COMManDs Control of LDL Cholesterol Levels
Keating, M. F., & Calkin, A. C. (2018) · Circulation Research · doi:10.1161/circresaha.118.313074 · Cited by 3
“Indeed, these findings mimic those observed in Ldlr/Lrp-deficient mice.(11) This begs the question, what other lipoprotein receptors are regulated by the CCC complex.”
BackgroundCholesterol metabolism: increasingly complex
Julio Sanhueza, C., Valenzuela, R., & Valenzuela, A. (2012) · Grasas y Aceites · doi:10.3989/gya.035512 · Cited by 3
“Para la regulación del transporte de colesterol hasta la MIM, PAP7 se uniría a la subunidad regulatoria de la PKA, permitiendo una activación de StAR mediante fosforilación, resultando en un rápido traspaso de colesterol desde StAR a PBR, trasladando así el colesterol desde la MEM hacía la MIM, donde la enzima P450scc…”
BackgroundInfluentialManturthi, S., Narayan, K. P., & Patri, S. V. (2023) · ChemistrySelect · doi:10.1002/slct.202302649 · Cited by 1
Metadata
- Authors
- Rohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Max Delbrück Center (DE)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-02-01
- Volume
- 101
- Issue
- 3
- Pages
- 689-695
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508614
- OpenAlex
- W2067089828
- Cited by
- 455
- References
- 33
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 14 · 2021: 13 · 2020: 9 · 2019: 9 · 2018: 18 · 2017: 15 · 2016: 14 · 2015: 16 · 2014: 8 · 2013: 17 · 2012: 19
- FWCI
- 33.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- LDL receptor-related protein, LRP, chylomicron remnants, cholesterol clearance, LDL receptor, conditional gene targeting, Cre-loxP recombination, liver, LDL receptor-deficient mice, lipoprotein metabolism
- MeSH terms
- Animals, Chylomicrons, Liver, Mice, Inbred C57BL, Mice, Transgenic, Receptors, Immunologic, Receptors, LDL, Recombination, Genetic, Viral Proteins, Mice, Knockout, Integrases, Low Density Lipoprotein Receptor-Related Protein-1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.